NONSURGICAL TREATMENT OF HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS

被引:75
作者
OHTO, M
YOSHIKAWA, M
SAISHO, H
EBARA, M
SUGIURA, N
机构
[1] First Department of Medicine, School of Medicine, Chiba University, Chiba, Inohana, Cyuo-ku
关键词
D O I
10.1007/BF00316978
中图分类号
R61 [外科手术学];
学科分类号
摘要
Modern imaging modalities have allowed us to make reliable diagnosis of hepatocellular carcinoma (HCC). Most of HCCs are associated with liver cirrhosis in varying stages of severity and often accompanied by new occurrences of HCC after treatment. Now, newly developed nonsurgical therapeutic modalities are used extensively and achieve good results in terms of anti-tumor effects as well as post-treatment survival.
引用
收藏
页码:42 / 46
页数:5
相关论文
共 50 条
[21]   INTRAPERITONEAL BLEEDING DUE TO SPONTANEOUS RUPTURE OF HEPATOCELLULAR-CARCINOMA IN 2 CIRRHOTIC-PATIENTS [J].
ALWAFAI, I ;
SHANABO, A ;
ALADNANI, MS ;
MAHAJAN, K .
JOURNAL OF THE KUWAIT MEDICAL ASSOCIATION, 1985, 19 (02) :157-162
[22]   INJECTION SCLEROTHERAPY FOR BLEEDING ESOPHAGEAL-VARICES IN CIRRHOTIC-PATIENTS WITH HEPATOCELLULAR-CARCINOMA [J].
NG, WD ;
CHAN, YT ;
HO, KK ;
KONG, CK .
GASTROINTESTINAL ENDOSCOPY, 1989, 35 (01) :69-70
[23]   CHEMOEMBOLIZATION FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS - ASSESSMENT OF EFFICACY ON TOTAL HEPATECTOMY SPECIMENS [J].
DUVOUX, C ;
CHERQUI, D ;
VANNHIEU, JT ;
VAVASSEUR, D ;
ZAFRANI, ES ;
MATHIEU, D ;
FAGNIEZ, PL ;
DHUMEAUX, D .
TRANSPLANTATION PROCEEDINGS, 1994, 26 (06) :3572-3573
[24]   DOES AN EARLY DIAGNOSIS OF HEPATOCELLULAR-CARCINOMA (HCC) IMPROVE SURVIVAL IN CIRRHOTIC-PATIENTS [J].
FARINATI, F ;
ZAGOLIN, M ;
CHIARAMONTE, M ;
FLOREANI, A ;
FAGIUOLI, S ;
NACCARATO, R .
GUT, 1988, 29 (10) :A1492-A1492
[25]   A NEW APPROACH FOR LIVER SURGERY - TRANSDIAPHRAGMATIC HEPATECTOMY FOR CIRRHOTIC-PATIENTS WITH HEPATOCELLULAR-CARCINOMA [J].
SHIMADA, M ;
MATSUMATA, T ;
TAKETOMI, A ;
SHIRABE, K ;
YAMAMOTO, K ;
ITASAKA, H ;
SUGIMACHI, K .
ARCHIVES OF SURGERY, 1995, 130 (02) :157-160
[26]   THE HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS - PREVALENCE, RISK-FACTORS AND NATURAL COURSE [J].
LEANDRO, G ;
ELBA, S ;
ZIZZARI, S ;
PETRUZZI, J ;
PICCIGALLO, E ;
MANGHISI, OG .
DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (10) :S79-S79
[27]   ANTIBODIES TO MUTANT P53 IN CIRRHOTIC-PATIENTS WITH AND WITHOUT HEPATOCELLULAR-CARCINOMA [J].
DEMICHELE, AMSG ;
COZZOLONGO, R ;
QUARANTA, M .
HEPATOLOGY, 1995, 22 (04) :1545-1545
[28]   OXIDATIVE-METABOLISM IN CIRRHOTIC-PATIENTS WITH AND WITHOUT HEPATOCELLULAR-CARCINOMA - EFFECTS OF MALNUTRITION [J].
GUGLIELMI, FW ;
MASTRONUZZI, T ;
DEMARCO, M ;
LADDAGA, L ;
PANELLA, C ;
FRANCAVILLA, A .
HEPATOLOGY, 1992, 16 (05) :1144-1149
[29]   ROLE OF SERUM FERRITIN AS MARKER OF HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS - A BAYESIAN-ANALYSIS [J].
LEANDRO, G ;
ZIZZARI, S ;
PRIMAVERA, MV ;
ELBA, S ;
PETRUZZI, J ;
MANGHISI, OG .
DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (10) :S424-S424
[30]   HEPATIC RESECTION OR ORTHOTOPIC LIVER-TRANSPLANT IN CIRRHOTIC-PATIENTS WITH SMALL HEPATOCELLULAR-CARCINOMA [J].
VARGAS, V ;
CASTELLS, L ;
BALSELLS, J ;
CHARCO, R ;
GONZALEZ, A ;
MARGARIT, C ;
ESTEBAN, R ;
GUARDIA, J .
TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) :1243-1244